U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Tue Apr 01 23:11:43 GMT 2025
Edited
by admin
on Tue Apr 01 23:11:43 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
F27LAH6D5O
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ABT-165
Preferred Name English
DILPACIMAB
INN   USAN  
Official Name English
IMMUNOGLOBULIN, ANTI-(NOTCH LIGAND DLL4/VASCULAR ENDOTHELIAL GROWTH FACTOR) (SYNTHETIC HUMAN PR-1283233 HEAVY CHAIN), DISULFIDE WITH SYNTHETIC HUMAN PR-1283233 LIGHT CHAIN, DIMER
Common Name English
PR-1283233
Code English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS DELTA-LIKE PROTEIN 4 (DROSOPHILA DELTA HOMOLOG 4, DELTA4)) AND ANTI-(HOMO SAPIENS VASCULAR ENDOTHELIAL GROWTH FACTOR A (VASCULAR PERMEABILITY FACTOR, VEGF-A, VPF)), DUAL VARIABLE DOMAIN HUMANIZED MOUSE MONOCLON
Systematic Name English
Dilpacimab [WHO-DD]
Common Name English
dilpacimab [INN]
Common Name English
DILPACIMAB [USAN]
Common Name English
Code System Code Type Description
INN
10863
Created by admin on Tue Apr 01 23:11:43 GMT 2025 , Edited by admin on Tue Apr 01 23:11:43 GMT 2025
PRIMARY
SMS_ID
100000183537
Created by admin on Tue Apr 01 23:11:43 GMT 2025 , Edited by admin on Tue Apr 01 23:11:43 GMT 2025
PRIMARY
CAS
1791420-09-1
Created by admin on Tue Apr 01 23:11:43 GMT 2025 , Edited by admin on Tue Apr 01 23:11:43 GMT 2025
PRIMARY
FDA UNII
F27LAH6D5O
Created by admin on Tue Apr 01 23:11:43 GMT 2025 , Edited by admin on Tue Apr 01 23:11:43 GMT 2025
PRIMARY
USAN
GH-95
Created by admin on Tue Apr 01 23:11:43 GMT 2025 , Edited by admin on Tue Apr 01 23:11:43 GMT 2025
PRIMARY
NCI_THESAURUS
C116750
Created by admin on Tue Apr 01 23:11:43 GMT 2025 , Edited by admin on Tue Apr 01 23:11:43 GMT 2025
PRIMARY
From To
1_22 1_96
1_146 1_220
1_274 1_330
1_391 1_451
1_497 1_555
1_356 2_356
1_359 2_359
1_350 3_334
2_22 2_96
2_146 2_220
2_274 2_330
2_391 2_451
2_497 2_555
2_350 4_334
3_23 3_88
3_143 3_208
3_254 3_314
4_23 4_88
4_143 4_208
4_254 4_314
Glycosylation Link Type Site
N 1_427
N 2_427
Related Record Type Details
.DELTA.-LIKE PROTEIN 4
TARGET -> INHIBITOR
HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A
TARGET -> INHIBITOR
Related Record Type Details
DILPACIMAB
ACTIVE MOIETY
immunomodulator, antineoplastic
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966